首页>
外国专利>
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING CHOLESTEROL LOWERING AGENTS AND H3 RECEPTOR ANTAGONIST/INVERSE AGONIST.
TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING CHOLESTEROL LOWERING AGENTS AND H3 RECEPTOR ANTAGONIST/INVERSE AGONIST.
展开▼
机译:使用胆固醇降糖剂和H3受体拮抗剂/逆激动剂治疗非酒精性脂肪肝疾病。
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention provides for method for the treatment, prevention or ameliorating the symptoms of nonalcoholic fatty liver disease (NAFLD) in a mammal in need thereof comprising the step of administering an effective amount of a composition comprising a therapeutic combination of at least one cholesterol lowering agent and/or at least one H3 antagonist/inverse agonist.
展开▼